McKesson Corp. (MCK) stock showed extreme strength and potential of active bulls that made the price surpass the $445.00 mark. On October 5, 2023, MCK stock outperformed and marked its 52-week high at $448.05. Notably, the opening price in yesterday’s session was $444.92 where the stock dropped to $444.11 and noted closing at $445.80.
Bullish Journey Followed by MCK Stock
It can be seen that MCK stock has shown bullish sentiments since the beginning of this year. This still shows its rising graph. The stock price showed over 27% and 19% growth in one year and year-to-date (YTD) analysis, respectively. In continuation, in the last month and after the release of the recent quarter result, MCK stock mostly traded near its 20 and 50-day moving averages.
The rising graph of MCK stock clearly showed potential bulls’ support while bears have also tried to get back in the trading field. However, as investors found the stock’s strength they actively participated in the trading activity which led to its price moving upwards. In addition, the RSI also moved upside down and began its journey towards the overbought zone.
In the past 3 months, analysts have given a “buy” rating to MCK stock. Meanwhile, the analysts have set their price target for MCK stock at $478.54, up over 7% from its recent closing price. Their maximum estimate is resting at $510.00 while the minimum estimate is at $427.00.
The Fundamentals of McKesson
McKesson Corporation (NYSE: MCK), an American healthcare company, has a market cap of nearly $60.21 Billion. MCK price-to-sales ratio is 0.21 and the company has an Enterprise Value to EBITDA ratio of 12.25. MCK dividends are paid on a quarterly basis. The last dividend per share was $0.62 and as of today, the Dividend Yield (TTM)% is 0.51%.
Earlier in August 2023, the company released its Q1 2023 report that stated its net income in the quarter was $958.00 Million. MCK earnings per share (EPS) for the quarter is $7.27 whereas the estimation was $5.87 which accounts for a 23.91% surprise. The revenue for the same Q1 2023 amounts to $74.48 Billion despite the estimated figure of $70.28 Billion.
The estimated EPS for the next quarter is $6.13, and the revenue is expected to reach $75.85 Billion. In 2022, the revenue of McKesson Corp. amounted to $276.71 Billion. Out of which, $240.62 Billion came from its highest performing source at the moment, “United States pharmaceutical.”
Disclaimer
The views and opinions stated by the author, or any people named in this article, are for informational ideas only and do not establish financial, investment, or other advice. Investing in or trading crypto or stock comes with a risk of financial loss.
Nancy J. Allen is a crypto enthusiast and believes that cryptocurrencies inspire people to be their own banks and step aside from traditional monetary exchange systems. She is also intrigued by blockchain technology and its functioning.
Source: https://www.thecoinrepublic.com/2023/10/06/mck-stock-price-showed-strong-trading-day-marked-52-week-high/